Anbogen, Receives Anbogen Therapeutics Taiwan United States of America United Kingdom 07.08.2025 - 18:00:23 Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer View original content:https://www.prnewswire.co.uk/news-releases/anbogen-receives-fda-clearance-to-initiate-phase-12-trial-of-abt-301-triplet-therapy-for-advanced-colorectal-cancer-302520502.html
